Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial
Feils, A. S., Erbe, A. K., Birstler, J., Kim, K., Hoch, U., Currie, S. L., Nguyen, T., Yu, D., Siefker-Radtke, A. O., Tannir, N., Tolaney, S. M., Diab, A., Sondel, P. M.
Published in Cancer Immunology, Immunotherapy (01.07.2023)
Published in Cancer Immunology, Immunotherapy (01.07.2023)
Get full text
Journal Article
Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy
Hoefges, Anna, Mcilwain, Sean J, Erbe, Amy K, Mathers, Nicholas N, Xu, Angie E, Melby, Drew, Tetreault, Kaitlin, Le, Trang Q, Kim, Kyungmann, Pinapati, Richard S, Garcia, Brad, Patel, Jigar, Heck, Mackenzie, Feils, Arika, Tsarovsky, Noah, Hank, Jacquelyn A, Morris, Zachary S, Ong, Irene M, Sondel, Paul M
Published in bioRxiv (24.02.2023)
Published in bioRxiv (24.02.2023)
Get full text
Paper
Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
Erbe, A K, Wang, Wei, Grzywacz, B, Ranheim, E A, Hank, J A, Kim, K, Carmichael, L, Seo, S, Mendonca, E A, Song, Y, Hong, F, Gascoyne, R D, Paietta, E, Horning, S H, Kahl, B, Sondel, P M
Published in Journal for immunotherapy of cancer (07.11.2013)
Published in Journal for immunotherapy of cancer (07.11.2013)
Get full text
Journal Article
Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy
Hoefges, A, McIlwain, S J, Erbe, A K, Mathers, N, Xu, A, Melby, D, Tetreault, K, Le, T, Kim, K, Pinapati, R S, Garcia, B, Patel, J, Heck, M, Feils, A S, Tsarovsky, N, Hank, J A, Morris, Z S, Ong, I M, Sondel, P M
Published in bioRxiv : the preprint server for biology (28.04.2023)
Get more information
Published in bioRxiv : the preprint server for biology (28.04.2023)
Journal Article